Table 1. Correlation analysis between c-Met with cancer stem cell or undifferentiated markers in all stage, stage 0, I, II and stage III, IV of breast tumors.
| mRNA co-expression MET vs. | ALL Stage | Stage I-II | Stage III-IV | |||
|---|---|---|---|---|---|---|
| Pearson's Correlation | p-value | Pearson's Correlation | p-value | Pearson's Correlation | p-value | |
| ALDH1A1 | 0.06 | 0.008 | 0.05 | 0.058 | -0.03 | 0.736 |
| ALDH1A3 | 0.22 | <0.001 | 0.21 | <0.001 | 0.40 | <0.001 |
| CD44 | 0.02 | 0.381 | 0.01 | 0.857 | 0.04 | 0.637 |
| CD133 | 0.30 | <0.001 | 0.31 | <0.001 | 0.40 | <0.001 |
| KLF4 | 0.10 | <0.001 | 0.11 | <0.001 | 0.12 | 0.181 |
| MYC | 0.14 | <0.001 | 0.15 | <0.001 | 0.17 | 0.055 |
| NANOG | -0.04 | 0.064 | -0.02 | 0.560 | 0.01 | 0.895 |
| NOTCH1 | 0.17 | <0.001 | 0.16 | <0.001 | 0.43 | <0.001 |
| NOTCH3 | 0.06 | 0.010 | 0.02 | 0.449 | 0.22 | 0.017 |
| OCT4 | 0.02 | 0.325 | 0.00 | 0.888 | 0.35 | <0.001 |
| SOX2 | 0.00 | 0.882 | 0.01 | 0.730 | -0.05 | 0.609 |
| STAT3 | -0.03 | 0.156 | -0.05 | 0.078 | -0.05 | 0.558 |
| BMI1 | -0.16 | <0.001 | -0.17 | <0.001 | -0.20 | 0.023 |